GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (LTS:0IHV) » Definitions » Cyclically Adjusted Price-to-FCF

Enzo Biochem (LTS:0IHV) Cyclically Adjusted Price-to-FCF : (As of May. 12, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Enzo Biochem Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzo Biochem Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Enzo Biochem's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Cyclically Adjusted Price-to-FCF Chart

Enzo Biochem Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Enzo Biochem Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Enzo Biochem's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Enzo Biochem's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Cyclically Adjusted Price-to-FCF falls into.


;
;

Enzo Biochem Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Enzo Biochem's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2025 is calculated as:

For example, Enzo Biochem's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jan. 2025 (Change)*Current CPI (Jan. 2025)
=-0.04/134.0288*134.0288
=-0.040

Current CPI (Jan. 2025) = 134.0288.

Enzo Biochem Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201504 -0.048 99.824 -0.064
201507 0.084 100.691 0.112
201510 0.274 100.346 0.366
201601 0.139 99.957 0.186
201604 -0.076 100.947 -0.101
201607 0.765 101.524 1.010
201610 -0.018 101.988 -0.024
201701 -0.058 102.456 -0.076
201704 0.004 103.167 0.005
201707 0.029 103.278 0.038
201710 0.045 104.070 0.058
201801 -0.050 104.578 -0.064
201804 -0.040 105.708 -0.051
201807 -0.053 106.324 -0.067
201810 -0.140 106.695 -0.176
201901 -0.321 106.200 -0.405
201904 0.467 107.818 0.581
201907 -0.078 108.250 -0.097
201910 -0.049 108.577 -0.060
202001 -0.128 108.841 -0.158
202004 -0.092 108.173 -0.114
202007 -0.136 109.318 -0.167
202010 -0.038 109.861 -0.046
202101 -0.028 110.364 -0.034
202104 0.011 112.673 0.013
202107 -0.030 115.183 -0.035
202110 -0.146 116.696 -0.168
202201 -0.038 118.619 -0.043
202204 -0.035 121.978 -0.038
202207 -0.194 125.002 -0.208
202210 -0.192 125.734 -0.205
202301 -0.145 126.223 -0.154
202304 -0.116 127.992 -0.121
202307 -0.353 128.974 -0.367
202310 -0.272 129.810 -0.281
202401 -0.178 130.124 -0.183
202404 -0.059 132.289 -0.060
202407 -0.023 132.708 -0.023
202410 -0.181 133.182 -0.182
202501 -0.040 134.029 -0.040

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzo Biochem  (LTS:0IHV) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Enzo Biochem Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem Business Description

Traded in Other Exchanges
Address
21 Executive Boulevard, Farmingdale, NY, USA, 11735
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Enzo Biochem Headlines

No Headlines